FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Humco Holding Group Thyroid Recall

Thyroid, USP (Porcine) Levothyroxine 36

Humco Holding Group, Inc · Texarkana, TX

Risk level
Class II
Reported by FDA
Oct 24, 2018
Recall ID
D-0023-2019
Check your lot numberHow we source this data

Summary

Humco Holding Group recalled Thyroid starting Aug 28, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0023-2019 on Oct 24, 2018. Reason: CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine. Status: Terminated.

Why it was recalled

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Product description

Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 100 grams NDC 0395-8077-62 Packaged by: Humco Texarkana, TX 75501 USA

Lot numbers, UPCs & expiration codes

Lots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0023-2019
Classification
Class II
Status
Terminated
Recall initiated
Aug 28, 2018
FDA report date
Oct 24, 2018
Quantity
Unknown.
Recall type
Voluntary: Firm initiated
Recalling firm
Humco Holding Group, Inc

Original FDA data

Every field from FDA enforcement report D-0023-2019, exactly as published.

Show all FDA fields
City
Texarkana
State
TX
Status
Terminated
Country
United States
Event ID
81061
Address
7400 Alumax Rd
Code information
Lots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019
Postal code
75501-0282
Report date
Oct 24, 2018
Product type
Drugs
Recall number
D-0023-2019
Classification
Class II
Recalling firm
Humco Holding Group, Inc
Product quantity
Unknown.
Termination date
May 7, 2020
Reason for recall
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 100 grams NDC 0395-8077-62 Packaged by: Humco Texarkana, TX 75501 USA
Distribution pattern
Nationwide.
Recall initiation date
Aug 28, 2018
Initial firm notification
Letter
Center classification date
Oct 12, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0023-2019, published Oct 24, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls